T-cell Non-Hodgkin's Lymphoma
4 clinical trials · Condition
◉ Watch T-cell Non-Hodgkin's Lymphoma
| Record | Firm | Date |
|---|---|---|
| Chidamide Plus CHOEP Combined With Upfront ASCT in Untreated Peripheral T-cell Lymphoma (NCT02987244) | Peking Union Medical College Hospital | 2016-03-01 |
| Pharmacokinetic Study of Forodesine in Children With Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non- Hodgkin's Lymphoma. (NCT00742495) | Mundipharma Research Limited | 2009-03-01 |
| A Phase II Study of Single-Agent Lenalidomide in Subjects With Relapsed Or Refractory T-Cell Non-Hodgkin's Lymphoma (NCT00655668) | Celgene | 2008-03-01 |
Track T-cell Non-Hodgkin's Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.